Comparative Pharmacology
Head-to-head clinical analysis: EDETATE CALCIUM DISODIUM versus PENTETATE ZINC TRISODIUM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EDETATE CALCIUM DISODIUM versus PENTETATE ZINC TRISODIUM.
EDETATE CALCIUM DISODIUM vs PENTETATE ZINC TRISODIUM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chelates heavy metals (e.g., lead, cadmium) by forming stable complexes with divalent and trivalent cations, which are then excreted in urine.
Pentetic acid (diethylenetriaminepentaacetic acid, DTPA) forms stable chelates with metal ions, particularly radioactive transuranic elements such as plutonium, americium, and curium. The zinc trisodium salt exchanges zinc for the radioactive metal, forming a stable, soluble complex that is rapidly excreted via the kidneys, thereby reducing radiation exposure.
Edetate calcium disodium is administered intravenously or intramuscularly. For lead poisoning: 1000 mg/m²/day IV continuous infusion or in divided doses every 12 hours; alternatively 50 mg/kg/day IV or IM in divided doses every 8-12 hours. Maximum 3000 mg/day. Duration typically 5 days, repeat after 2 days rest. For other heavy metal toxicity: 50 mg/kg/day IV or IM in divided doses every 8-12 hours for 3-5 days.
1 g intravenous infusion over 1-2 hours once daily for up to 5 days.
None Documented
None Documented
Terminal elimination half-life approximately 1.5-3 hours for the intact chelate; prolonged to 20-40 hours in lead-intoxicated patients due to redistribution of lead from bone.
The terminal elimination half-life is approximately 1.5 to 2 hours for the Zn-DTPA complex in patients with normal renal function. In the setting of acute radiation exposure, this rapid clearance allows for early chelation.
Primarily renal (90-100% as chelated lead complex within 24-48 hours); minimal biliary/fecal excretion (<5%).
Primarily renal elimination of the chelated complex (e.g., Zn-DTPA). In adults, >95% of the administered dose is excreted unchanged in urine within 24 hours, with minor biliary/fecal excretion (<5%).
Category C
Category C
Chelating Agent
Chelating Agent